Results 101 to 110 of about 26,646 (226)
The switch from patented medicine to the generic one: an option or a necessity? [PDF]
, 2018 This paper assesses the influence of a number of factors taken into account when a brand name drug is replaced by a generic one. It also evaluates responses of health professionals – physicians and pharmacist—and patients regarding the issue of switching.
Adriana Elena, Nica +8 more
core +1 more source
PharmaceuticsAs the field of personalized dosing develops, the pharmaceutical manufacturing industry needs to offer flexibility in terms of tailoring the drug release and strength to the individual patient’s needs.
Olha Shuklinova +7 more
doaj +1 more source
Planning and evaluation of bioequivalence studies of rosuvastatin drug products
Регуляторные исследования и экспертиза лекарственных средств, 2018 The article reviews bioequivalence studies of Russian and foreign generic rosuvastatin preparations with the goal of harmonizing approaches to rosuvastatin bioequivalence studies in the Russian Federation.
D. P. Romodanovsky, D. V. Goryachev
doaj
Phentolamine bioequivalence study.
International journal of clinical pharmacology and therapeutics, 2004 To assess the bioequivalence of 2 tablet formulations of phentolamine (Regitine phentolamine 40 mg tablet formulation by Novartis, Brazil, as test formulation, and Vasomax, phentolamine 40 mg tablet formulation by Schering Plough S.A., Brazil, as reference formulation).A single 40 mg oral dose of each formulation was administered to 36 male healthy ...
Silva, LFG +5 more
openaire +2 more sources
On equivalence and bioequivalence testing. [PDF]
, 2017 Equivalence testing is the natural approach to many statistical problems. First, its main application, bioequivalence testing, is reviewed. The basic concepts of bioequivalence testing (2×2 crossover designs, TOST, interval inclusion principle, etc.) and
Carrasco Jordan, Josep Lluís +3 more
core
Determination of bioequivalence for drugs with narrow therapeutic index [PDF]
, 2014 The US Food and Drug Administration (FDA) has recently suggested that the bioequivalence (BE) for products of drugs with narrow therapeutic indices (NTI) be assessed by the approach of reference-scaled average BE (SABE). Subsequently, in December, 2012,
Endrenyi L, Tóthfalusi László
core
Effects of 'Authorized-Generics' on Canadian Drug Prices [PDF]
This paper examines how the use of ‘authorized-generics’ (AGs) influences Canadian prescription drug prices. An authorized-generic is the actual brand name drug product, manufactured by the brand firm, but sold as a generic by a licensee or subsidiary of
Paul Grootendorst
core
On equivalence and bioequivalence testing [PDF]
, 2008 Equivalence testing is the natural approach to many statistical problems. First, its main application, bioequivalence testing, is reviewed. The basic concepts of bioequivalence testing (2×2 crossover designs, TOST, interval inclusion principle, etc ...
Carrasco Jordan, Josep Lluís +3 more
core
Testing for Multivariate Equivalence with Random Quadratic Forms [PDF]
, 2005 Multivariate equivalence testing becomes necessary whenever the similarity rather than a difference between several treatment groups with multiple endpoints has to be shown.
Weißbach, Rafael
core +1 more source
Citation: 'bioequivalence' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.15154 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms. Requests for commercial
openaire +1 more source